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Abstract 
Background 
Tonsillitis is a common condition with an incidence in UK general practice of 37 per 
1000 population a year1.  Recurrent tonsillitis results in significant morbidity and 
impacts on individuals’ quality of life. This study assesses the morbidity and quality 
of life of adults with recurrent tonsillitis, and the impact of surgical intervention on 
their health state.  
Objectives 
1. To describe disease specific and global quality of life for adults with recurrent 
tonsillitis six months after tonsillectomy, using two instruments: the Health 
Impact of Throat Problems (HITP) and EuroQol-visual analogue scale (EQ-VAS) 
questionnaire.  
2. To assess the overall health benefit from tonsillectomy as an intervention using 
the Glasgow Benefit Inventory (GBI). 
3. To assess potential predictors of tonsillectomy benefit.  
Design 
A prospective, observational cohort audit of patients who have fulfilled Scottish 
Intercollegiate Guideline Network (SIGN) criteria for tonsillectomy2.   
Setting: Secondary care, teaching hospital 
Participants: Seventy patients (57 female), median age 20 years (range 13-41).  
Results 
Median pre-operative HITP was 47 (range 15-67), compared to 4 (0-72), (p< 0.001) 6 
months following surgery. Median HITP difference was 39.5 (range -20 to 75). There 
was no significant change in global Quality of Life. Median overall 6 months GBI 
was 39 (-3-100). Patients had an average of 27 episodes of tonsillitis over a period of 
seven years before “achieving” tonsillectomy, significantly higher than the SIGN 
guidelines of three or more episodes over three years.  
Conclusions 
Recurrent tonsillitis causes a poor disease specific quality of life.  Patients 
experienced a median of three episodes per year for seven years before 
tonsillectomy.  Following tonsillectomy, patients had a significant improvement in 
their disease specific quality of life.  Baseline HITP significantly improved after 
tonsillectomy. The results imply patients with recurrent acute tonsillitis may be 
experiencing undue delay 
 
Introduction 
Tonsillectomy is one of the most commonly performed surgical procedures in the 
UK  accounting for 20% of all operations performed by otolaryngologists and we 
have national guidelines in place giving recommendations on when tonsillectomy 
should be performed2. Tonsillitis is a common condition with an incidence in 
general practice of 37 per 1000 population a year, in the UK1 4. Recurrent tonsillitis 
results in significant morbidity, including time off work5. The effectiveness of 
tonsillectomy for recurrent tonsillitis in adults is still controversial. Several studies 
have demonstrated that tonsillectomy is followed by clinically important 
improvements in patient health 6,7.  However, a recent large scale prospective study 
assessing the overall health related quality of life in otolaryngology patients found 
only a small overall benefit from tonsillectomy8. A recent Cochrane Review 
concluded that “Insufficient information is available on the effectiveness of adeno-
/tonsillectomy versus non-surgical treatment in adults to draw a firm conclusion.”9    
Our team is contributing to the UK NAtional Trial of Tonsillectomy IN Adults 
(NATTINA), a nationally funded trial aiming to provide level one evidence for 
tonsillectomy.   The randomised controlled trial in adults examining tonsillectomy 
versus medical treatment is currently recruiting patients in the UK but results will 
not be available for some years10. 
The aims of this prospective audit were to assess 
1. The morbidity of tonsillitis in adults with regards to disease specific and global 
and quality of life, using a both a disease specific and global quality of life tool. 
2. The impact of tonsillectomy on these quality of life measures. 
3. The extent of any derived health benefit from tonsillectomy.    
Materials and Methods 
Ethical considerations 
This prospective audit was approved by the hospital clinical effectiveness 
department. The clinical effectiveness department collected all completed 
questionnaires from the ENT clinic, gave each patient a unique study number, 
entered the results into an anonymised database and sent out follow up 
questionnaires.  All follow up questionnaires were returned to the clinical 
effectiveness department and data was entered into an anonymised database.  The 
completed anonymised database was transferred to author W.M.W for analysis. 
 
Entry and Exclusion Criteria 
Entry criteria for the study were based on the indication for tonsillectomy.  All 
patients that were recruited had been listed electively for tonsillectomy due to 
recurrent tonsillitis, being identified from general ENT clinics.  It was the policy of 
the local health board that patients aged 13 and above were treated in the adult 
hospital, therefore there were a small number of teenagers included in the study.  
All patients were listed for tonsillectomy.  After being listed, while in the clinic, they 
were invited to participate in the audit.  
Exclusion criteria were as follows: suspected tonsil malignancy11, tonsillectomy for 
sleep disordered breathing12, adenotonsillectomy, revision tonsil surgery, patients 
listed directly from emergency inpatient admission. Patient recruitment ran for one 
year. 
Any method of dissection removal of the palatine tonsils was included in the audit 
(cold steel, bipolar).  
 
Questionnaires 
The Health Impact of Throat problems (HITP) questionnaire was used as the disease 
specific questionnaire.  It is a 16 item questionnaire that is a translation of the 
Tonsillectomy Outcome Inventory 14 questionnaire13 with two additional questions 
(snoring and halitosis).  The two additional questions were originally in the first 
phase of validation for the TOI 14 questionnaire.   The TOI14 is being used to assess 
throat related quality of life in adults in NATTINA10. The 16 items offer categorical 
response options graded 0 to 5 (5 = most severe; 0 = no problem), reflecting patients’ 
experience of symptoms over the previous six months.  Total Score thus ranges 
from 0–80, with a higher score reflecting poorer throat related quality of life. 
1) The EuroQol Visual Analogue Scale (EQ-VAS) was used as the global quality of 
life questionnaire.  It is a visual analogue scale that records the respondent’s 
self-rated health on a vertical, visual analogue scale where the endpoints are 
labelled “Best imaginable health state” (100) and “Worst imaginable health state” 
(0).  This information can be used as a quantitative measure of health outcome 
as judged by the individual respondents.   
2) The Glasgow Benefit Inventory (GBI) was chosen as it has been widely used in 
otolaryngology to assess benefit derived following an intervention. The GBI 
poses 18 questions concerning change in health status resulting from the 
intervention/ management.  The response to each question is based on a five-
point Likert-type scale; these are then scaled and averaged to give a final score.  
The score ranges from -100 to +100, with negative scores meaning a worse 
outcome after intervention, zero meaning no change and a positive score 
representing benefit. The GBI has three domains, general health, social support 
and physical health, with six items per domain, which can be examined 
independently.  
Patients completed the EuroQol-visual analogue scale (EQ-VAS) and health impact 
of throat problems (HITP) at enrolment in the study before tonsillectomy was 
performed.  Patients also provided demographic data (age, sex) indicated the number 
of episodes of sore throat per year, and duration of history in years.   Six months’ 
after tonsillectomy, EQ-VAS, HITP and a GBI were sent to each patient for 
completion.  
 
Statistical Analysis 
All analyses were performed using SPSS v. 21 (IBM). Responses on all 
questionnaires were first tested for normality using the one-sample Kolmogorov-
Smirnov tests. Multiple measures were shown to have a skewed distribution, hence 
non-parametric tests were used to analyse differences (related-samples Wilcoxon 
signed rank test; rank-sum test for gender differences) and correlations (Spearman’s 
rho). Variables correlated were pre and post op EQ-VAS, EQ-VAS difference, GBI 
Total and subscales, pre and post op HITP, HITP difference, age, sore throat 
episodes.  
  
Results 
From 123 patients (Male: Female ratio, 1:2) who were listed for tonsillectomy due to 
recurrent tonsillitis, 105 proceeded to surgery and were eligible for the study. 18 
patients decided not to proceed to surgery.  Seventy (67%) patients fully completed 
all pre and post op questionnaires. The median age was 20 years (range 13-41), with 
13 males and 57 females. The mean duration of tonsillitis was 7.3 years with the 
mean number of episodes each year being 3.8 – an average of 27 episodes prior to 
tonsillectomy.  The SIGN compliance rate was 96%.   
 
EuroQol-Visual Analogue Scale  
The median pre-operative EQ-VAS score was 85 (40-100) increasing to 90 (40-100) 
post operatively (z = 1.65; p = 0.10). The median pre-post difference was-3 (range -
60-60). Forty-one (59%) patients had an EQ-VAS improvement, 17 patients had a 
lower score and 12 patients had no change.   EQ-VAS scores were independent of 
gender.   
 
Health Impact of Throat Problems 
The median pre-operative score on the HITP was 47 (range 15 to 67).  The median 
postoperative HITP score was 4 (0 to 72), a very substantial decrease (p< 0.001). The 
median pre-post operative difference was 39.5 (-20-75). Sixty-five patients (93%) had 
an improvement in their HITP score post tonsillectomy. Results were independent 
of gender.   
 
GBI 
The median overall postoperative benefit as assessed by the GBI was 39 (-3 to 100, 
Table 1).  Overall and subscale GBI scores, as well as all three subscales, showed a 
statistically significant benefit (i.e., either the median was significantly positive, or 
in the case of the Social Support subscale, the skew was significantly positive). 
There was a slightly greater median score among female respondents (42) in the GBI 
general subscale than in males (29, z = 2.28; p = 0.02). 
 
Table 1.  Overall GBI and subscales.   
 Overall GBI General Social Support Physical 
Health 
Median 39 42 0 67 
Range -3 to100 4 to 100 -17 to100 -83 to 100 
Z 7.21 7.28 3.99 6.60 
P < 0.001 < 0.001 < 0.001 < 0.001 
 
Correlations 
As age increased, the pre operative EQ-VAS decreased. Significant correlations are 
shown in Table 2. The post operative EQ-VAS correlated with overall, general and 
physical health subscales of the GBI. The post operative HITP correlated with the 
physical health subscale of the GBI and the post operative EQ-VAS.  The GBI social 
support scale was median rank zero and not surprisingly therefore failed to show 
any meaningful correlations.  
Table 2.  Significant Correlations (Spearman’s rho) between GBI/GBI subscales, HITP 
and EQ-VAS  
 GBI Total 
GBI 
General 
GBI 
Physical 
Health 
Postop 
EQ-
VAS 
Preop 
HITP 
Age 
GBI General 0.963*      
GBI Physical Health 0.673* 0.522*     
Preop EQ-VAS      -0.379* 
Postop  EQ-VAS 0.368* 0.339* 0.4*    
Postop  HITP   -0.349* -0.367*   
HITP Difference     0.793*  
*Asterisk indicates statistically significant correlations at α = 0.05 with Bonferroni 
correction for multiple comparisons (i.e. actual α = 0.005). 
 
There was no correlation between HITP and the total number of sore throat 
episodes per person.  The pre-op HITP showed no correlations.   
Discussion 
This study highlights the hidden morbidity that patients with recurrent tonsillitis 
suffer, with patients having an average of 27 episodes of tonsillitis before 
“achieving” tonsillectomy, waiting an average of seven years in the process. The 
intervention of tonsillectomy significantly improved the HITP score (p<0.0001), 
suggesting that tonsillectomy does significantly improve the disease specific burden 
of chronic tonsillitis. 
 
Benefit of Tonsillectomy compared to other ENT procedures.   
The median overall GBI was considerably higher than some retrospective reports of 
tonsillectomy (17 to 35) in the presence of  lower completion rates compared to our 
study (67% vs. 26- 39%6,14,15).  It was also higher than certain prospective reports 
with less stringent entry criteria 7,16. A GBI median score of 39 is very favourable in 
comparison to other common ENT procedures including septal surgery (5 - 1517,18) 
or  functional endoscopic sinus surgery, ( 2319), and  comparable to surgery for 
hearing impairment (34 -40)5,16.  The very high level of physical health benefit has 
been reported previously  as has the nonresponsiveness of GBI social wellbeing to 
tonsillectomy7.  
 
Benefit of Tonsillectomy compared to other general operations. 
In 2009 McKinsey reported that £700m of NHS funding is unnecessarily spent on 
operations with limited clinical benefit, which include tonsillectomy, varicose vein 
surgery and inguinal hernia surgery20.  This study adds to the body of literature 
already published that shows tonsillectomy is, on the contrary, highly effective in 
treating adults with recurrent tonsillitis6,7. This series of patients is the first series to 
use EQ-VAS pre and post operatively. The median pre operative score is high was 
85, comparable to the mean score of the UK national questionnaire survey on 
general health status - 82.521.  Forty-one patients (59%) reported an increase in 
general health as measured by the EQ-VAS, which is comparable to the most recent 
Department of Health figures for hip and knee replacement surgery (65% increase of 
health and 55.1% increase respectively).  Interestingly, only 37% of groin hernia 
patients report an increase in general health after surgery and only 40% of varicose 
vein patients22. It may be that the EQ-VAS alone is not sensitive enough to identify 
a statistically significant change in global quality of life, and was an inappropriate 
choice of assessment tool for this study. It may also be that the high score reflects a 
ceiling effect and tonsillitis does not have a significant impact on the EQ-VAS.  
Furthermore, the stringent (SIGN) entry criteria may have so tightly grouped 
patients that the data dispersion is too narrow to detect any such variance. 
 
Value of SIGN Guidelines 
This study highlights the consequences of the more or less universal take up  of the 
SIGN guidelines, which to date lack supporting Level 1 evidence in adults2. Previous 
tonsillectomy audits have largely sought to endorse guideline compliance, by 
demonstration that surgery is confined to those with a ‘qualifying minimum’ 
number of episodes to warrant tonsillectomy23,24.  Conversely, avoidance of surgery 
unless SIGN criteria are met, has presumably contributed to the significant drop in 
tonsillectomy numbers over the past decade25. However, this study has shown that 
there is a, hidden morbidity from recurrent tonsillitis that is not currently being 
addressed.   The current patient pathway in Scotland has lead patients to experience 
two to three times more tonsillitis than the minimum required by current SIGN 
guidelines.  However, unfortunately we don’t have historical data to demonstrate 
conclusively if this morbidity has always been present, even before SIGN was 
introduced.  The associated morbidity that comes with this is highlighted by the 
significant change in HITP after tonsillectomy.  Recurrent tonsillitis not only causes 
a disease burden to the individual patient but also results in a wider burden to 
society due to lost work days and recurrent health care utilization.  With the lack of 
evidence for the current SIGN guidelines then other tools should be considered to 
help select patients for tonsillectomy and a tool such as HITP may be of more value.    
 
Weakness of Study 
This study had a follow up period of six months.  As patients experienced an 
average of 3.4 sore throats per year, then it may be that longer follow up may not 
have demonstrated as much benefit.  Furthermore, 33% of the participants that 
completed the first set of questionnaires did not complete the second set of 
questionnaires.  Although the demographics of this group were similar to the group 
that completed all questionnaires we were unable to contact those that didn’t 
respond despite multiple attempts.   
 
In summary our audit demonstrates that patients with recurrent tonsillitis 
experience prolonged morbidity (7 years on average), SIGN guidance has usefully 
supported the avoidance of surgery for milder sore throats. Now, however, primary 
and secondary care clinicians, together with purchasers of healthcare need to 
refocus on the prolonged and excessive morbidity experience by those with 
moderate or severe episodes. Until the ongoing NATTINA study provides Level I 
evidence concerning tonsillectomy effectiveness, clinicians should review their own 
patient pathways and facilitate earlier access to surgery where excessive delay is 
demonstrated. 
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